首页> 外文期刊>International Journal of Molecular Sciences >Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
【24h】

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

机译:非酒精性脂肪性肝炎(NASH)的发病机理和治疗靶点包括氧化应激在内的多次命中

获取原文
           

摘要

Multiple parallel hits, including genetic differences, insulin resistance and intestinal microbiota, account for the progression of non-alcoholic steatohepatitis (NASH). Multiple hits induce adipokine secretion, endoplasmic reticulum (ER) and oxidative stress at the cellular level that subsequently induce hepatic steatosis, inflammation and fibrosis, among which oxidative stress is considered a key contributor to progression from simple fatty liver to NASH. Although several clinical trials have shown that anti-oxidative therapy can effectively control hepatitis activities in the short term, the long-term effect remains obscure. Several trials of long-term anti-oxidant protocols aimed at treating cerebrovascular diseases or cancer development have failed to produce a benefit. This might be explained by the non-selective anti-oxidative properties of these drugs. Molecular hydrogen is an effective antioxidant that reduces only cytotoxic reactive oxygen species (ROS) and several diseases associated with oxidative stress are sensitive to hydrogen. The progress of NASH to hepatocellular carcinoma can be controlled using hydrogen-rich water. Thus, targeting mitochondrial oxidative stress might be a good candidate for NASH treatment. Long term clinical intervention is needed to control this complex lifestyle-related disease.
机译:多重平行命中,包括遗传差异,胰岛素抵抗和肠道菌群,解释了非酒精性脂肪性肝炎(NASH)的进展。多次命中在细胞水平上诱导脂肪因子分泌,内质网(ER)和氧化应激,随后诱发肝脂肪变性,炎症和纤维化,其中氧化应激被认为是从单纯性脂肪肝向NASH演变的关键因素。尽管一些临床试验表明抗氧化疗法可以在短期内有效控制肝炎的活动,但长期效果仍然不明显。旨在治疗脑血管疾病或癌症发展的长期抗氧化剂方案的数项试验未能产生益处。这些药物的非选择性抗氧化特性可能解释了这一点。分子氢是一种有效的抗氧化剂,仅能减少细胞毒性的活性氧(ROS),与氧化应激相关的几种疾病对氢敏感。使用富含氢的水可以控制NASH向肝细胞癌的进展。因此,靶向线粒体的氧化应激可能是NASH治疗的良好选择。需要长期的临床干预来控制这种复杂的生活方式相关疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号